Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression

Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression

Stereotactic ablative radiotherapy (SABR) may improve survival in patients with inoperable pulmonary oligometastases. However, the impact of pulmonary oligometastatic status after systemic therapy on SABR outcomes remains unclear. Hence, we investigated the outcomes of SABR in 45 patients with 77 lu...

Full description

Bibliographic Details
Main Authors:	Chin-Beng Ho, Jo-Ting Tsai, Chun-You Chen, Her-Shyong Shiah, Hsuan-Yu Chen, Lai-Lei Ting, Chia-Chun Kuo, I-Chun Lai, Hsin-Yi Lai, Chi-Li Chung, Kai-Ling Lee, Huey-En Tzeng, Kuen-Haur Lee, Hsin-Lun Lee, Shang-Wen Chen, Jeng-Fong Chiou
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Diagnostics
Subjects:	pulmonary metastases oligometastases oligoprogression extrapulmonary disease metastasectomy stereotactic ablative radiotherapy (SABR)
Online Access:	https://www.mdpi.com/2075-4418/13/9/1597

Similar Items

Stereotactic Body Radiotherapy for Extracranial Oligometastatic Disease from Head and Neck Primary Cancers: A Systematic Review and Meta-Analysis
by: Adam Mutsaers, et al.
Published: (2024-02-01)

Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer
by: Shuai Li, et al.
Published: (2019-10-01)

Stereotactic Radiation for Oligometastatic and Oligoprogressive Stage IV Breast Cancer: A Case-Based Review
by: Gary M. Freedman, et al.
Published: (2023-02-01)

Uncovering the armpit of SBRT: An institutional experience with stereotactic radiation of axillary metastases
by: A. Mutsaers, et al.
Published: (2024-03-01)

Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done
by: Austin J. Bartl, et al.
Published: (2022-02-01)

Developments in Stereotactic Body Radiotherapy
by: Anoop Haridass
Published: (2018-12-01)

Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements
by: Chiara Pisano, et al.
Published: (2022-01-01)

Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
by: Shao-Lun Lu, et al.
Published: (2016-08-01)

The Effectiveness and Safety of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Oligoprogressive Breast Cancer: A Systematic Review
by: Bernie Yan, et al.
Published: (2023-07-01)

Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk
by: Philipp Hoegen, et al.
Published: (2023-03-01)

PSMA-PET/CT-Based Stereotactic Body Radiotherapy (SBRT) in the Treatment of Uncomplicated Non-Spinal Bone Oligometastases from Prostate Cancer
by: Edoardo Pastorello, et al.
Published: (2023-05-01)

Successful treatment of induced oligometastasis and repeated oligoprogression of advanced lung adenocarcinoma with immunotherapy and radiotherapy
by: Ho Young Lee, et al.
Published: (2022-07-01)

Oligoprogression of Solid Tumors on Immune Checkpoint Inhibitors: The Impact of Local Ablative Radiation Therapy
by: Kunal K. Sindhu, et al.
Published: (2022-10-01)

Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter Century
by: Sara Mheid, et al.
Published: (2023-10-01)

The Emerging Role of Radiation Therapy in Renal Cell Carcinoma
by: Michael Christensen, et al.
Published: (2022-09-01)

Systemic Therapy for Oligoprogression in Patients with Metastatic NSCLC Harboring Activating EGFR Mutations
by: Antonio Rossi, et al.
Published: (2022-02-01)

Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockade
by: Kunal K. Sindhu, et al.
Published: (2020-01-01)

Oligometastases of Esophageal Squamous Cell Carcinoma: A Review
by: Yuta Sato, et al.
Published: (2024-02-01)

Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
by: Goda G. Kalinauskaite, et al.
Published: (2020-05-01)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
by: Rosario Mazzola, et al.
Published: (2019-04-01)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
by: Fabian Weykamp, et al.
Published: (2020-06-01)

The Management of Oligoprogression in the Landscape of New Therapies for Metastatic Melanoma
by: Michele Guida, et al.
Published: (2019-10-01)

Local Treatment of Hepatocellular Carcinoma with Oligometastases: A Systematic Review and Meta-Analysis
by: Sooyeon Kim, et al.
Published: (2023-07-01)

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
by: Martijn van Dorp, et al.
Published: (2023-10-01)

Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patients
by: Pang-Shuo Perng, et al.
Published: (2023-11-01)

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
by: Robert Olson, et al.
Published: (2018-10-01)

Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival
by: Takaya Yamamoto, et al.
Published: (2020-10-01)

Stereotactic Body Radiotherapy versus Surgery for Lung Metastases from Colorectal Cancer: Single-Institution Results
by: Nagore Garcia-Exposito, et al.
Published: (2023-02-01)

Stereotactic Body Radiotherapy and Immunotherapy for Older Patients with Oligometastases: A Proposed Paradigm by the International Geriatric Radiotherapy Group
by: Nam P. Nguyen, et al.
Published: (2022-12-01)

Stereotactic ablative body radiation therapy for isolated pulmonary metastases from pancreatic cancer after metastectomy with positive margins: a case report
by: Anoud Alnsour, et al.
Published: (2023-06-01)

Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma
by: Rohit K. Raj, et al.
Published: (2023-12-01)

Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer
by: Antonin Levy, et al.
Published: (2023-07-01)

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
by: Gregor Habl, et al.
Published: (2017-05-01)

The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases
by: N. Andratschke, et al.
Published: (2018-03-01)

Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors
by: Stephan Rheinheimer, et al.
Published: (2020-04-01)

Definitive irradiation as a first treatment strategy for primary and metastatic sites of newly diagnosed IVB cervical cancer that presented with synchronous oligometastases
by: Junyun Li, et al.
Published: (2023-09-01)

First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac
by: Tomas M. Janssen, et al.
Published: (2022-06-01)

Role of Consolidative Stereotactic Body Radiation Therapy in Oligoresistant/Oligoprogressive Pulmonary Parenchymal Metastases
by: Berber T, et al.
Published: (2022-08-01)

A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases
by: Fumagalli Ingrid, et al.
Published: (2012-09-01)

Oligoprogression in Non-Small Cell Lung Cancer
by: Daijiro Harada, et al.
Published: (2021-11-01)